NXTAG COV EXTENDED PANEL
Report
- Report Number
- 3002777243-2021-00002
- Event Type
- Malfunction
- Date Received
- June 17, 2021
- Date of Event
- February 22, 2021
- Report Date
- June 10, 2021
- Manufacturer
- LUMINEX MOLECULAR DIAGNOSTICS, INC.
- Product Code
- QJR
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THERE WAS NO REPORTED INJURY OR DEATH AT THE TIME OF THIS REPORT. THE MDR IS BEING SUBMITTED UNDER DEVIATION (B)(4). PURSUANT TO THE OBLIGATIONS OF THE EMERGENCY USE AUTHORIZATION, AND PER COMMUNICATION RECEIVED FROM FDA ON OCTOBER 7, 2020.
ON (B)(6) 2021, THE CUSTOMER REPORTED THAT THEY HAVE RECENTLY SEEN SOME SAMPLES COME UP POSITIVE FOR ONLY ORF1AB AND E GENES WITH STRONG SIGNALS, BUT NO SIGNAL FOR THE N GENE. THEY WERE CURIOUS IF THIS WAS A RESULT OF THE NEW VARIANT GENE. TECHNICAL SUPPORT NOTED THAT THIS IS NOT A DISCREPANCY SINCE ONLY 1 TARGET NEEDS TO BE POSITIVE (N, ORF1AB, OR P GENE) IN ORDER TO GET COV POSITIVE. TECHNICAL SUPPORT REQUESTED THE DATA AND CHECKED TO SEE IF THE CUSTOMER COULD SHIP THE SAMPLES IN QUESTION TO LUMINEX FOR VARIANT EVALUATION. ON (B)(6) 2021, THE CUSTOMER NOTIFIED TECHNICAL SUPPORT THAT THEY WILL BE REPEATING THE SAMPLES THAT WERE POTENTIAL VARIANTS (NO N GENE DETECTED) AND WILL SHIP THESE SAMPLES TO LUMINEX FOR POTENTIAL SEQUENCING IF THE RESULTS REPEAT. CONCLUSION: ON (B)(6) 2021, THE CUSTOMER CONFIRMED THAT ALL THE REPEATS CAME BACK NEGATIVE SO THEY WILL NOT SEND THE SAMPLES TO LUMINEX FOR SEQUENCING. CUSTOMER ALSO CONFIRMED THAT ALL THE POSITIVE CONTROLS/INTERNAL CONTROLS WERE FINE. FURTHER INVESTIGATION WAS NOT NEEDED ANYMORE. AT THIS TIME, THIS CASE WILL BE SUBMITTED AS AN MDR BASED ON FDA'S GUIDANCE RECEIVED ON OCTOBER 7TH, 2020.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 918630 | NXTAG COV EXTENDED PANEL | NXTAG COV EXTENDED PANEL | QJR | LUMINEX MOLECULAR DIAGNOSTICS, INC. | IK054C-0050, IK054C-0051 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |